American Heart Journal
Volume 154, Issue 1 , Pages 151-157 , July 2007

Does coronary angioplasty after timely thrombolysis improve microvascular perfusion and left ventricular function after acute myocardial infarction?

  • Luciano Agati, MD

      Affiliations

    • Department of Cardiology, “La Sapienza” University, Rome, Italy
    • Corresponding Author InformationReprint requests: Luciano Agati, MD, Department of Cardiology, “La Sapienza” University of Rome, Rome, Italy.
    • ,
  • Stefania Funaro, MD

      Affiliations

    • Department of Cardiology, Catholic University, Campobasso, Italy
    • ,
  • Mariapina Madonna, MD

      Affiliations

    • Department of Cardiology, “La Sapienza” University, Rome, Italy
    • ,
  • Gennaro Sardella, MD, FACC, FESC

      Affiliations

    • Department of Cardiology, “La Sapienza” University, Rome, Italy
    • ,
  • Barbara Garramone, MD

      Affiliations

    • Institute of Cardiology, Catholic University, Rome, Italy
    • ,
  • Leonarda Galiuto, MD, PhD, FACC

      Affiliations

    • Institute of Cardiology, Catholic University, Rome, Italy

Received 12 October 2006 ,Accepted 19 March 2007.

References 

  1. Nallamothu BK, Bates ER, Herrin J, et al. for the NRMI investigators Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. Circulation. 2005;111:761–767
  2. Huber K, De Caterina R, Kristensen SD, et al. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J. 2005;26:2063–2074
  3. Antman EM, Van de Werf F. Pharmacoinvasive therapy. The future treatment for ST-elevation myocardial infarction. Circulation. 2004;109:2480–2486
  4. Le May MR, Wells GA, Labinaz M, et al. Combined angioplasty and pharmacological intervention vs thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol. 2005;46:417–424
  5. Mc Clell AJ, Owens CG, Walsh SJ, et al. Percutaneous coronary intervention a 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction. Eur Heart J. 2005;26:544–548
  6. Gibson CM, Karha J, Murphy SA, et al. for the TIMI Study Group Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol. 2003;42:7–16
  7. Scheller B, Hennen B, Hammer B, et al. for the SIAM III Study Group Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 2003;42:634–641
  8. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. on the behalf of the GRACIA Group Routine invasive strategy within 24 hours after thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet. 2004;363:1045–1053
  9. Steg PG, Bonnefoy E, Chabaud S, et al. for the Comparison of Angioplasty Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Investigators Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from CAPTIM randomized clinical trial. Circulation. 2003;108:2851–2856
  10. Armstrong PW, WEST Steering Committee . A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J. 2006;27:1530–1538
  11. Collet JP, Montalescot G, Le May M, et al. Percutaneous coronary intervention after fibrinolysis. A multiple meta-analysis approach to the type of strategy. J Am Coll Cardiol. 2006;48:1326–1335
  12. Agati L, Funaro S, Veneroso G, et al. Clinical utility of contrast echocardiography in the management of patients with acute myocardial infarction. Eur Heart J. 2002;4(Suppl C):C27–C34
  13. Agati L, Tonti G, Pedrizzetti G, et al. Clinical application of quantitative analysis in real-time MCE. Eur J Echocardiography. 2004;45(Suppl 2):S9–S15
  14. Agati L, Voci P, Bilotta F, et al. Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. J Am Coll Cardiol. 1994;24:336–342
  15. Agati L, Voci P, Hickle P, et al. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction. J Am Coll Cardiol. 1998;31:338–343
  16. Agati L. Microvascular integrity after reperfusion therapy. Am Heart J. 1999;138:76–79
  17. Galiuto L, Lombardo A, Maseri A. Temporal evolution and functional outcome of no-reflow: sustained and spontaneously reversible patterns following successful coronary recanalization. Heart. 2003;89:731–737
  18. Fernandez-Aviles F, Alonso JJ, Pena G, et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA 2 non-inferiority, randomized, controlled trial. Eur Heart J. 2007;[electronic publication ahead of print]
  19. Svensson L, Aasa M, Delborg M, et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with ST-segment elevation myocardial infarction. The Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J. 2006;151:798 e1–798 e7
  20. Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention (Assent-4 PCI) Investigators . Primary vs. tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367:569–578
  21. Verheugt FWA. Lyse now, stent later: the grace of GRACIA. Lancet. 2004;364:1014–1015
  22. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699–1705
  23. Costantini CO, Stone GW, Mehran R, et al. Frequency, correlates and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa, in acute myocardial infarction. J Am Coll Cardiol. 2004;44:305–312
  24. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957–966

PII: S0002-8703(07)00252-9

doi: 10.1016/j.ahj.2007.03.028

American Heart Journal
Volume 154, Issue 1 , Pages 151-157 , July 2007

Article Tools

* Image Usage & Resolution